Cigna Group announced Monday it is not pursuing a merger with Humana. The announcement squashes speculation fueled by Donald ...

"The Cigna Group remains committed to its established M&A criteria and would only consider acquisitions that are ...

Analyst Steve Baxter of Wells Fargo maintained a Hold rating on Cigna (CI – Research Report), retaining the price target of $355.00.

Additionally, in light of recent and persistent speculation, The Cigna Group expects to communicate that the company is not ...

Last December, the two companies failed to agree on a price as Cigna pursued the purchase of the Louisville-based company.

LOUISVILLE, Ky. — The Cigna group announced on Monday they would no longer be pursuing a merger with their Louisville-based ...

The potential merger of Cigna and Humana could have a better chance of success than under the Democrats, though we still see increasing claims concentration in the PBM industry as a concern. Also, the ...

Shares of Humana had been among the major health-care gainers in the wake of Donald Trump's victory as traders anticipated a Trump administration approving merger plans that Federal Trade Commission ...

The Cigna Group (NYSE: CI) said on Monday that it is officially not pursuing a combination with Humana Inc. (NYSE: HUM). That means that CenterWell Home ...

Cigna confirms it won't pursue a combination with rival, Humana. Glen Losev of Bloomberg Intelligence is on "Bloomberg Radio.

Company officials said Monday they are not pursuing a merger with rival Humana, causing Cigna's stock to rise in the markets.

Cigna Group said Monday it is not pursuing a combination with rival Humana, days after Donald Trump's reelection as U.S. president raised investor hopes that any merger would face far less antitrust ...